Rising Prevalence Of Cardiovascular Disease Boosts Transdermal Skin Patches Market: Strengthening the Growth Trajectory of the Transdermal Skin Patches Market

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Transdermal Skin Patches Market Size By 2025?
The market size for transdermal skin patches has seen consistent growth in the past few years. The market is projected to expand from $7.46 billion in 2024 to $7.72 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.5%. This growth during the historic period can be accredited to the escalation of cardiovascular diseases, significant economic progress in developing markets, the amplified expenditure on pharmaceutical research and development, and an uptick in healthcare spending.

How Big Is the Transdermal Skin Patches Market Size Expected to Grow by 2029?
Expectations are high for steady expansion in the transdermal skin patches market over the coming years, with projections of the market size reaching $9.36 billion in 2029 at a growth pace of 4.9% CAGR. The anticipated growth during this forecast period may be due to several factors including escalating rates of smoking cessation, rapid aging of the global population, increasing expenditure in healthcare and the rising incidence of cardiovascular diseases. The trend profile for the projection period may encompass technological advancements in transdermal skin patches, progress in diabetes transdermal patches, strong research and development endeavors, innovative products, collaborations and partnerships, wearable skin patches, advancements in microneedle patches for vaccinations and novel iontophoresis patches.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transdermal-skin-patche-global-market-report

Which Key Market Drivers Powering Transdermal Skin Patches Market Expansion and Growth?
The rising occurrence of cardiovascular disease is predicted to significantly contribute to the expansion of the transdermal skin patches market. Cardiovascular diseases are conditions affecting the heart and blood vessels, often associated with the buildup of fatty deposits inside the arteries, known as atherosclerosis, and an increased chance of blood clots. Transdermal skin patches are commonly administered to stop angina episodes in individuals with coronary artery disease, a condition epitomized by blood vessel constriction leading to the heart. These patches are also used to enhance bioavailability in treating heart failure. For instance, a study published by the American College of Cardiology in August 2022 highlighted that all four cardiovascular risk factors in the United States are projected to rise from 2025 to 2060. The highest expected surge is in diabetes, estimated to go up by 39.3% to hit 55 million individuals, followed by dyslipidemia (increased by 27.6% to 126 million), hypertension (increased by 25.1% to 162 million), and obesity (increased by 18.3% to 126 million). The study also pinpointed the most considerable projected surges in cardiovascular disease rates were strokes (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attacks (16.9% to 16 million). Hence, the escalating occurrence of cardiovascular disease is spurring the progression of the transdermal skin patches market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2829&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Transdermal Skin Patches Market?
Leading corporations in the transdermal skin patches market are sharpening their competitive edge by centring their efforts around the launch and approval of inventive products. These innovative products offer new or enhanced solutions such as drugs, medical devices, or other products to cater to existing issues or needs. Illustratively, in March 2022, U.S pharmaceutical company, Noven Pharmaceuticals Inc., made public the approval of their XELSTRY (dextroamphetamine) transdermal system by the U.S. Food and Drug Administration (FDA). This system is a unique, first-of-its-kind approved amphetamine patch aimed at treating ADHD (Attention-Deficit or Hyperactivity Disorder). XELSTRYM should be deployed two hours prior when an effect is necessary and should be removed nine hours later. The final dosage should be customized based on clinical response and tolerability.

What Are the Emerging Segments in the Transdermal Skin Patches Market?
The transdermal skin patches market covered in this report is segmented -

1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor
2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types
3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications

Subsegments:
1) By Matrix: Drug-in-matrix Patches, Polymer Matrix Patches
2) By Drug In Adhesive: Adhesive Matrix Patches With The Drug Incorporated In The Adhesive Layer
3) By Reservoir: Drug Reservoir Patches With A Separate Compartment For The Drug, Multi-layer Reservoir Patches
4) By Vapor: Vapor Patches That Release Active Ingredients In Vapor Form, Transdermal Patches Utilizing Vaporization Technology

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2829&type=smp

Who Are the Global Leaders in the Transdermal Skin Patches Market?
Major companies operating in the transdermal skin patches market include Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Pharmaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy's Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Europlaz Technologies Ltd, Zentiva, Medical-Łomża Sp. z o.o., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Endo Pharmaceuticals Inc.

Which are the Top Profitable Regional Markets for the Transdermal Skin Patches Industry?
North America was the largest region in the global transdermal skin patches market in 2024. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2829

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe - +44 7882 955267
Asia: +91 88972 63534
Americas - +1 310-496-7795
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.